Economic Model to Evaluate the Cost-Effectiveness of Second-Line Nilotinib Versus Dasatinib for the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (CML-CP)...

por Bonifacio, Massimiliano, Maheshwari, Vikalp, Tran, Diana, Agostoni, Gianluca, Filioussi, Kalitsa, Viana, Ricardo
Publicado 2021